Preparations and methods for the treatment of t cell mediated diseases
CA 2226013 C · Owner: Yeda Research And Development Co. Ltd. · Inventors: Elias, Dana; Shinitzky, Meir; Cohen, Irun R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Metabolizable lipid emulsions, such as Intralipid and Lipofundin are , excellent vehicles for peptide therapy of autoimmune diseases and of other TH1 T cell mediated diseases or conditions as it promotes a TH1 to TH2 cytokine , shift. Such emulsions may be used in conjunction with an antigen recognized by inflammatory T cells associated with the pathogenesis of a T cell mediated disease or condition for the therapeutic treatment of such a condition.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 2, 1996 and granted September 18, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 2, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 2, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.